BOCA RATON, Fla.--(BUSINESS WIRE)--University Lab Technologies announced today the filing with the United States patent office for Zenstral PMS, a product for the treatment of Premenstrual Syndrome (PMS).
Today's announcement follows the recent ARTHOLEVE ULT™ patent and marks the second of several patents the company has planned for the evidence based nutraceutical products in its product development pipeline.
